To prepare samples for 2,3-DPG measurement, 2 ml of venous blood in heparinized tubes was collected, placed immediately on ice, deproteinized with 0.6 M perchloric acid (Sigma-Aldrich, Saint Louis, MO, United States) to lyse RBC, and neutralized with 2.5 M potassium carbonate (Sigma-Aldrich, Saint Louis, MO, United States). The supernatant was kept for at least 60 min in an ice bath and centrifuged at 3,000 × g for 10 min. The supernatant was stored at 28°C, and 2,3-DPG levels were measured using the Roche diagnostic kit (no. 10148334001). The Roche 2,3-DPG assay is based on enzymatic cleavage of 2,3-DPG, and oxidation of nicotinamide adenine dinucleotide recorded by spectrophotometry. The 2,3-DPG assays were performed in three batches and in the range of 0.02–0.15 μmol. Concentration of 2,3-DPG was calculated according to the procedure proposed by the manufacturer. The 2,3-DPG levels were normalized to the corresponding hematocrit value from the same sample. Since the concentration of 2,3-DPG rapidly decreases during storage (Hamasaki and Yamamoto, 2000; Llohn et al., 2005), the procedure for determining the 2,3-DPG level was performed immediately after taking the blood samples. Determination of 2,3-DPG level was carried out in duplicate on each sample. The reliability of 2,3-DPG measurement was evaluated based on the coefficient of variation (CV) using the test–retest method (Atkinson and Nevill, 1998). CV for 2,3-DPG was between 0.30 and 0.76%, which indicates that these measurements are characterized by a high degree of reliability.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.